Full coverage: Start-ups

Neil Hosty, the chief executive of the Co Kerry financial exchange business, talks international expansion, acquiring the bureau de change arm of the British grocery chain, and why Ireland should be cautious around recreating France's start-up campus Station F.

Dara & Co was started nearly two years ago by Naomh McElhatton in the area of edtech and personal development. It has appointed liquidators to wind up the company.

Meta, Apple, and Snap have all bet big on augmented reality. Michael Guerin explains how Imvizar will be well placed to take advantage and why it's looking to Hollywood to raise €5m.

Aerska raised $21m recently for its RNA therapies tackling diseases like Alzheimer's. Co-founders Jack O’Meara and David Hardwicke talk to The Currency about what’s next.

The agency backs hundreds of early-stage companies. Executive director Kevin Sherry says it is now ramping up investment in later-stage firms.

He’s guarded doors in gay nightclubs, built multimillion-euro travel empires, and once rented his home to Taylor Swift. Now, entrepreneur Bob Haugh is plotting his next big journey — building his luxury travel company, OROKO.

Mina Mutafchieva and Irishman Jack McGuinness are among the first London hires for German venture firm HV Capital. They talk to The Currency about Europe's opportunity to lure US talent, the prospect of an AI bubble, and Ireland's start-up sector.

The start-up, often described as an "Uber for pathology", has just secured a crucial approval to carry out pathological testing in the UK. CEO Donal O'Shea speaks about building out its UK footprint and plans to scale up in the US.

Creditors fought to install an examiner over the objections of Senoptica CEO and co-founder Brendan Rice. An “unusual” committee of creditors has been installed to allay his concerns. 

Scientists and co-founders, Killian Hanlon and Hugh O’Brien, are using AI to redesign viruses for gene therapy. Lir Therapeutics has already raised $3m and is showing early results that could transform how diseases are treated.